157 related articles for article (PubMed ID: 37226562)
1. Long-Term Clinical Outcomes of Drug-Coated Balloon Treatment for De Novo Coronary Lesions.
Her AY; Kim B; Ahn SH; Park Y; Cho JR; Jeong YH; Shin ES
Yonsei Med J; 2023 Jun; 64(6):359-365. PubMed ID: 37226562
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
3. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
[TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH
Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516
[TBL] [Abstract][Full Text] [Related]
6. A Non-inferiority, Randomized Clinical Trial Comparing Paclitaxel-Coated Balloon Versus New-Generation Drug-Eluting Stents on Angiographic Outcomes for Coronary De Novo Lesions.
Yu X; Wang X; Ji F; Zhang W; Yang C; Xu F; Wang F
Cardiovasc Drugs Ther; 2022 Aug; 36(4):655-664. PubMed ID: 33713211
[TBL] [Abstract][Full Text] [Related]
7. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial.
Giacoppo D; Alvarez-Covarrubias HA; Koch T; Cassese S; Xhepa E; Kessler T; Wiebe J; Joner M; Hochholzer W; Laugwitz KL; Schunkert H; Kastrati A; Kufner S
Eur Heart J; 2023 Apr; 44(15):1343-1357. PubMed ID: 36807512
[TBL] [Abstract][Full Text] [Related]
8. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
9. Impact of Diabetes on Outcome With Drug-Coated Balloons Versus Drug-Eluting Stents: The BASKET-SMALL 2 Trial.
Wöhrle J; Scheller B; Seeger J; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger RV;
JACC Cardiovasc Interv; 2021 Aug; 14(16):1789-1798. PubMed ID: 34412797
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of less drug-eluting stents by the use of drug-coated balloons in
Wang X; Yang X; Lu W; Pan L; Han Z; Pan S; Shan Y; Wang X; Zheng X; Li R; Zhu Y; Qin P; Shi Q; Zhou S; Zhang W; Guo S; Zhang P; Qin X; Sun G; Qin Z; Huang Z; Qiu C
Front Cardiovasc Med; 2023; 10():1045859. PubMed ID: 36937919
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome.
Ma YL; Tang XF; Yao Y; Xu N; Song Y; Jiang P; Xu JJ; Wang HH; Jiang L; Liu R; Zhao XY; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
Chin Med J (Engl); 2018 Jun; 131(12):1397-1405. PubMed ID: 29893356
[TBL] [Abstract][Full Text] [Related]
13. Midterm safety and efficacy of elective drug-coated balloon angioplasty in comparison to drug-eluting stents for unrestrictive de novo coronary lesions: A single center retrospective study.
Yamada K; Ishikawa T; Nakamura H; Mizutani Y; Ukaji T; Shimura M; Kondo Y; Aoki H; Hisauchi I; Itabashi Y; Nakahara S; Kobayashi S; Taguchi I
J Cardiol; 2023 Jun; 81(6):537-543. PubMed ID: 36481299
[TBL] [Abstract][Full Text] [Related]
14. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of drug-eluting stent implantation for patients with multiple coronary chronic total occlusions.
Zhang J; Han YL; Li Y; Wang SL; Jing QM; Wang XZ; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2010 Apr; 123(7):789-93. PubMed ID: 20497665
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions.
Yang X; Lu W; Pan L; Han Z; Pan S; Wang X; Zhu Y; Shan Y; Peng M; Qin P; Zhang P; Qin X; Sun G; Qin Z; Dong J; Qiu C
Front Cardiovasc Med; 2022; 9():935263. PubMed ID: 36211569
[TBL] [Abstract][Full Text] [Related]
17. Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Seeger J; Wöhrle J; Scheller B; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Stachel G; Leibundgut G; Rickenbacher P; Cattaneo M; Gilgen N; Kaiser C; Jeger R; On Behalf Of The Basket-Small Investigators
J Cardiovasc Dev Dis; 2023 Mar; 10(3):. PubMed ID: 36975883
[TBL] [Abstract][Full Text] [Related]
18. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Outcome of Drug-Coated Balloon vs Drug-Eluting Stent for Small Coronary Vessels: PICCOLETO-II 3-Year Follow-Up.
Cortese B; Testa G; Rivero F; Erriquez A; Alfonso F
JACC Cardiovasc Interv; 2023 May; 16(9):1054-1061. PubMed ID: 37164603
[TBL] [Abstract][Full Text] [Related]
20. Short-term outcomes of drug-coated balloon versus drug-eluting stent for
Lin L; Lu W; Wang X; Pan L; Wang X; Zheng X; Li R; Shan Y; Peng M; Qiu C
Front Cardiovasc Med; 2023; 10():982880. PubMed ID: 36950290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
